海南越康生物医药

Hainan Yuekang Biological Medicine is a specialized biopharmaceutical subsidiary of the Yuekang Pharmaceutical Group, established to drive the industrialization of innovative therapies. Located in the Haikou National High-tech Zone, the company focuses on the development and large-scale manufacturing of nucleic acid drugs, mRNA vaccines, and high-end chemical medicines. It plays a pivotal role in the parent group's innovation-driven strategy, hosting advanced production lines for antisense oligonucleotides and viral vector-based products. The facility is designed to meet international GMP standards, supporting clinical trials and commercial supply for oncology and infectious disease indications. The company is central to the group's transition from traditional generics to cutting-edge biopharmaceuticals.